Optimal duration for dual antiplatelet therapy with COMBO ... | 合法醫療器材資訊網

COMBO Plus is more than just a drug-eluting stent (DES). It is a combination of traditional DES components with the addition of a biological coating. Read More

November 6, 2020: An assessment of the safety and clinical performance of the COMBO Plus Dual Therapy Drug-Eluting Stent (“COMBO stent”) shows ... Read More

Hong Kong [April 23, 2018] OrbusNeich has received regulatory approval to update the CE Mark labeling for COMBO Plus Dual Therapy Stent with important​ ... Read More

It is the first dual therapy stent to both accelerate endothelial coverage and control neointimal proliferation through the combination of the proven pro-healing​ ... Read More

由 K Yamaji 著作 · 2018 · 被引用 3 次 — While the original EPC capture stent without drug elution failed to show non-​inferiority to DES with regard to target lesion failure,10 a COMBO ... Read More

由 L Baldetti 著作 · 2018 · 被引用 2 次 — The COMBO stent is a new, sirolimus-eluting bioresorbable polymer, bioengineered stent. This technology combines the advantages of ... Read More

由 A Huseynov 著作 · 2019 — The COMBO stent (OrbusNeich Medical BV, the Netherlands) is a stainless-steel platform with the biodegradable abluminal coating containing antiproliferative ... Read More

2019年9月25日 — The COMBO Plus Coronary Stent is the first drug-eluting stent [DES] to combine the proprietary endothelial progenitor cell [EPC] capture ... Read More